Circulating endothelial cells and endothelial progenitor cells: Two sides of the same coin, or two different coins?

Atherosclerosis

Volumn 188, Issue 1, 2006, Pages 12-18

  Blann, Andrew D ^a   Pretorius, Adolf ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Circulating endothelial cells; Endothelial progenitor cells

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; VON WILLEBRAND FACTOR;

APOPTOSIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; BONE MARROW; CELL POPULATION; CYTOLOGY; ENDOTHELIUM CELL; HUMAN; IMMUNOCYTOCHEMISTRY; NECROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STEM CELL;

ANTIGENS, CD146; ANTIGENS, CD34; BLOOD CELLS; BLOOD CIRCULATION; ENDOTHELIAL CELLS; HUMANS; STEM CELLS;

EID: 33746503824     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.12.024     Document Type: Review

References (78)

1. Dignat-George F., and Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 65 (2000) 215-220
2. Blann A.D., Woywodt A., Bertolini F., et al. Circulating endothelial cells: biomarker of vascular disease. Thromb Haemost 93 (2005) 1-9
3. Woywodt A., Goldberg C., Scheer J., et al. A novel assay for the enumeration of circulating endothelial cells. Ann Hematol 83 (2004) 491-494
4. Makin A., Chung N.A.Y., Silverman S.H., et al. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Eur Heart J 25 (2004) 371-376
5. George F., Brouqui P., Boffa M.C., et al. Demonstration of Rickettsia conorrii-induced endothelial injury in-vivo by measuring circulating endothelial cells, thrombomodulin and von Willebrand factor in patients with Meditteranean spotted fever. Blood 82 (1993) 2109-2116
6. Kas-Deelen A.M., Harmsen M.C., de Maar E.F., et al. Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood. Kidney Int 58 (2000) 2533-2542
7. Bull T.M., Golpon H., Hebbel R.P., et al. Circulating endothelial cells in pulmonary hypertension. Thromb Haemost 90 (2003) 698-703
8. Woywodt A., Scheer J., Hambach L., et al. Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation. Blood 103 (2004) 3603-3605
9. McClung J.A., Naseer N., Saleem M., et al. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia 48 (2005) 345-350
10. Quilici J., Banzet N., Paule P., et al. Circulating endothelial cell count as a diagnostic marker for non-ST elevation acute coronary syndromes. Circulation 110 (2004) 1586-1591
11. Lee K.W., Lip G.Y., Tayebjee M., Foster W., and Blann A.D. Circulating endothelial cells, Von Willebrand Factor, interleukin-6 and prognosis in patients with acute coronary syndromes. Blood 105 (2005) 526-532
12. Mutunga M., Fulton B., Bullock R., et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 163 (2001) 195-200
13. Koc M., Richards H.B., Bihorac A., et al. Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney Int 67 (2005) 1078-1083
14. Mutin M., Canavy I., Blann A.D., et al. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 93 (1999) 2951-2958
15. Woywodt A., Streiber F., De Groot K., et al. Circulating endothelial cells as markers for ANCA-associated small vessel vasculitis. Lancet 361 (2003) 206-210
16. Butthep P., Rummavas S., Wisedpanichkij R., et al. Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumour necrosis factor in thalassaemia. Am J Hematol 70 (2002) 100-106
17. Solovey A., Gui L., Key N.S., and Hebbel R.P. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest 101 (1998) 1899-1904
18. Solovey Solovey A., Gui L., Ramakrishnan S., Steinberg M.H., and Hebbel R.P. Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. Blood 93 (1999) 3824-3830
19. Rajagopalan S., Somers E.C., Brook R.D., et al. Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Blood 103 (2004) 3677-3683
20. Beerepoot L.V., Mehra N., Vermaat J.S.P., et al. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 15 (2004) 139-145
21. Beerepoot L.V., Mehra N., Linschoten F., et al. Circulating endothelial cells in cancer patients do not express tissue factor. Cancer Lett 213 (2004) 241-248
22. Wang C., Li H., Fu P., Zhang S., and Xiu R. Serum C-reactive protein and circulating endothelial cells in patients with acute myocardial infarction. Clin Hemorheol Microcirc 32 (2005) 287-296
23. Stump M.M., Jordan Jr. G.L., Debakey M.E., and Halpert B. Endothelium grown from circulating blood on isolated Dacron hub. Am J Pathol 43 (1963) 361-367
24. Frazier O.H., Baldwin R.T., Eskin S.G., and Duncan J.M. Immunochemical identification of human endothelial cells on the lining of a ventricular assist device. Tex Heart Inst J 20 (1993) 78-82
25. Wu M.H., Shi Q., Wechezak A.R., et al. Definitive proof of endothelialization of a Dacron arterial prosthesis in a human being. J Vasc Surg 21 (1995) 862-867
26. Noishiki Y., Noishiki Y., Tomizawa Y., Yamane Y., and Matsumoto A. Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Nat Med 2 (1996) 90-93
27. Reyes M., Dudek A., Jahagirdar B., et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109 (2002) 337-346
28. Shi Q., Rafii S., Wu M.H., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 (1998) 362-367
29. Ikpeazu C., Davidson M.K., Halteman D., Browning P.J., and Brandt S.J. Donor origin of circulating endothelial progenitors after allogeneic bone marrow transplantation. Biol Blood Marrow Transpl 6 (2000) 301-308
30. Rookmaaker M.B., Tolboom H., Goldschmeding R., et al. Bone-marrow-derived cells contribute to endothelial repair after thrombotic microangiopathy. Blood 99 (2002) 1095 (Letter)
31. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
32. Berenson R.J., Andrews R.G., Bensinger W.I., et al. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 81 (1988) 951-955
33. Vaughan W.P., Civin C.I., Weisenburger D.D., et al. Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). Leukemia 2 (1988) 661-666
34. + cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
35. Quirici N., Soligo D., Caneva L., et al. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol 115 (2001) 186-194
36. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
37. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
38. Adams V., Lenk K., Linke A., et al. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol 24 (2004) 684-690
39. George J., Goldstein E., Abashidze S., et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 25 (2004) 1003-1008
40. Verma S., Kuliszewski M.A., Li S.H., et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109 (2004) 2058-2067
41. Eizawa T., Murakami Y., Matsui K., et al. Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin 19 (2003) 627-633
42. Eizawa T., Ikeda U., Murakami Y., et al. Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease. Heart 90 (2004) 685-686
43. Leone A.M., Rutella S., Bonanno G., et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 26 (2005) 1196-1204
44. Steiner S., Niessner A., Ziegler S., et al. Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. Atherosclerosis 181 (2005) 305-310
45. Szmitko P.E., Fedak P.W., Weisel R.D., et al. Endothelial progenitor cells: new hope for a broken heart. Circulation 107 (2003) 3093-4100
46. Rafii S., Lyden D., Benezra R., et al. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?. Nat Rev Cancer 2 (2002) 826-835
47. Rafii S., Meeus S., Dias S., et al. Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin Cell Dev Biol 13 (2002) 61-67
48. Rosenzweig A. Endothelial progenitor cells. N Engl J Med 348 (2003) 581-582
49. Masuda H., and Asahara T. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 58 (2003) 390-398
50. Stevens T., Rosenberg R., Aird W., et al. NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases. Am J Physiol Cell Physiol 281 (2001) C1422-C1433
51. Mancuso P., Burlini A., Pruneri G., et al. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 97 (2001) 3658-3661
52. Khan S.S., Solomon M.A., and McCoy Jr. J.P. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 64 (2005) 1-8
53. Lin Y., Weisdorf D.J., Solovey A., et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105 (2000) 71-77
54. Zhang H., Vakil V., Braunstein M., et al. Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 105 (2005) 3286-3294
55. Del Papa N., Colombo G., Fracchiolla N., et al. Circulating endothelial cells as markers of ongoing vascular disease in systemic sclerosis. Arthrit Rheum 50 (2004) 1296-1304
56. Nakatani K., Takeshita S., Tsujimoto H., et al. Circulating endothelial cells in Kawasaki disease. Clin Exp Immunol 131 (2003) 536-540
57. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
58. Lev E.I., Kleiman N.S., Birnbaum Y., et al. Circulating endothelial progenitor cells and coronary collaterals in patients with non-st segment elevation myocardial infarction. J Vasc Res 42 (2005) 408-414
59. Ingram D.A., Mead L.E., Moore D.B., et al. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105 (2005) 2783-2786
60. Choi J.H., Kim K.L., Huh W., et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 24 (2004) 1246-1252
61. Shintani S., Murohara T., Ikeda H., et al. Mobilisation of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
62. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
63. Gulati R., Jevremovic D., Peterson T.E., et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93 (2003) 1023-1025
64. Romagnani P., Annunziato F., Liotta F., et al. CD14+CD34low Cells With Stem Cell Phenotypic and Functional Features Are the Major Source of Circulating Endothelial Progenitors. Circ Res (2005) Epub ahead of print
65. Ingram D.A., Mead L.E., Tanaka H., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104 (2004) 2752-2760
66. Burger P.E., Coetzee S., McKeehan W.L., et al. Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood 100 (2002) 3527-3535
67. Fernandez Pujol B., Lucibello F.C., Gehling U.M., et al. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65 (2000) 287-300
68. Ingram D.A., Caplice N.M., and Yoder M.C. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood (2005) Published on line May 19
69. Moroni G., Del Papa N., Moronetti L.M., et al. Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease. Kidney Int 68 (2005) 562-568
70. Gulati R., Lerman A., and Simari R.D. Therapeutic uses of autologous endothelial cells for vascular disease. Clin Sci 109 (2005) 27-37
71. Lenk K., Adams V., Lurz P., et al. Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur Heart J (2005)
72. Assmus B., Schachinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
73. Britten M.B., Abolmalli N.D., Assmus B., et al. Infarct remodelling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI). Circulation 108 (2003) 2212-2218
74. Schachinger V., Assmus B., Britten M.B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44 (2004) 1690-1699
75. Stamm C., Westphal B., Kleine H.D., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
76. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
77. Rohde E., Malischnik C., Thaler D., et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells (2005) Epub ahead of print
78. Woywodt A, Blann AD, Kirsch, Erdbruegger U, Banzet N, Haubitz M, Dignat-George F. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: Proposal of a definition and a consensus protocol. J Thromb Haemostas 2006;4:in press.